Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 30, 2013
Protein C and protein S deficiency - practical diagnostic issuesEwa Wypasek, Anetta Undas
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|December 11, 2014
IgA Antiphospholipid Antibodies and Anti-Domain 1 of Beta 2 Glycoprotein 1 Antibodies are Associated with Livedo Reticularis and Heart Valve Disease in Antiphospholipid SyndromeMarek Cieśla, Ewa Wypasek, Anetta Undas
Mediators of Inflammation|March 17, 2005
Mast cells are responsible for the lack of anti-inflammatory effects of morphine in CBA miceElzbieta Stankiewicz, Ewa Wypasek, Barbara Plytycz
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|January 16, 2016
Determinants of Elevated Levels of Natural Anticoagulants in Healthy SubjectsBarbara Kościelniak, Ewa Wypasek, Anetta Undas
International Journal of Molecular Sciences|October 17, 2015
Association of the C-Reactive Protein Gene (CRP) rs1205 C>T Polymorphism with Aortic Valve Calcification in Patients with Aortic StenosisEwa Wypasek, Daniel P Potaczek, Anetta Undas
Kardiologia Polska|December 3, 2011
[Optimalisation of treatment with vitamin K antagonists--the role of gene polymorphisms]Ewa Stępień, Ewa Wypasek, Agnieszka Branicka, et al.
Thrombosis Research|September 8, 2014
Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndromeMichal Asztabski, Ewa Wypasek, Michał Ząbczyk, et al.
Scientific Reports|October 27, 2021
Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort studySandra Mrozinska, Ewa Wypasek, Elżbieta Broniatowska, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 2014
False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndromeTadeusz Góralczyk, Teresa Iwaniec, Ewa Wypasek, et al.
Folia Biologica|December 27, 2011
Morphine-modulated mast cell migration and proliferation during early stages of zymosan-induced peritonitis in CBA miceEwa Wypasek, Joanna Natorska, Elzbieta Stankiewicz, et al.
Pageof 8